NASDAQ:INKT

Mink Therapeutics Stock Signals

etoro logo Buy INKT
*Your capital is at risk
$12.00
-0.750 (-5.88%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -7.532 5 days ( 12.15 % )
Last Price $12.00 -5.88 %
High/ Low $12.00 - $12.90 -2.83%
Chg 7 Days -12.89 % $13.78 $12.00
Chg 30 Days -14.29 % $14.00 $12.00
Chg 12 mos 59.15 % $7.54 $12.00
Trend - 3 mos -9.23 % Width: 22.77 %
Trend - 12 mos 17.25 % Width: 529.03 %
Pred. range - 3 mos $11.33 - $13.91 -5.57 % - 15.93 %
Pred. range - 12 mos $12.63 - $79.47 5.28 % - 562.22 %
Short MA avg 3 mos Sell Nov 12, 2025 - 4 days
Long MA avg 3 mos Buy Oct 23, 2025 - 18 days
Short/Long MA avg 3 mos Sell Oct 10, 2025 - 27 days
Short MA avg 12 mos Sell Oct 27, 2025 - 16 days
Long MA avg 12 mos Sell Oct 27, 2025 - 16 days
Short/Long MA avg 12 mos Sell Oct 30, 2025 - 13 days
Pivot Short Sell Oct 02, 2025 - 33 days
Bollinger Buy Nov 17, 2025 - 1 day
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT MINK THERAPEUTICS, INC.
MiNK Therapeutics
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was former...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE